Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -Publisher
SPRINGER
DOI: 10.1007/s12035-021-02404-y
Keywords
Place preference; Mephedrone; Glutamate; MRS; Chromatography
Categories
Funding
- NCN [2017/25/B/NZ7/02410]
- National Science Centre (NSC, Poland)
Ask authors/readers for more resources
This study comprehensively evaluated the involvement of glutamatergic transmission in the rewarding effects of mephedrone using behavioral studies, in vivo magnetic resonance spectroscopy, and ion-exchange chromatography. The results showed that memantine could reverse the rewarding effects of mephedrone, while MRS study demonstrated an increase in glutamate levels in the hippocampus after subchronic mephedrone administration. Ex vivo chromatographic analysis supported the findings of the MRS study, providing new insights into glutamatergic involvement in mephedrone's rewarding properties.
Mephedrone is a widely used drug of abuse, exerting its effects by interacting with monoamine transporters. Although this mechanism has been widely studied heretofore, little is known about the involvement of glutamatergic transmission in mephedrone effects. In this study, we comprehensively evaluated glutamatergic involvement in rewarding effects of mephedrone using an interdisciplinary approach including (1) behavioural study on effects of memantine (non-selective NMDA antagonist) on expression of mephedrone-induced conditioned place preference (CPP) in rats; (2) evaluation of glutamate concentrations in the hippocampus of rats following 6 days of mephedrone administration, using in vivo magnetic resonance spectroscopy (MRS); and (3) determination of glutamate levels in the hippocampus of rats treated with mephedrone and subjected to MRS, using ion-exchange chromatography. In the presented research, we confirmed priorly reported mephedrone-induced rewarding effects in the CPP paradigm and showed that memantine (5 mg/kg) was able to reverse the expression of this effect. MRS study showed that subchronic mephedrone administration increased glutamate level in the hippocampus when measured in vivo 24 h (5 mg/kg, 10 mg/kg and 20 mg/kg) and 2 weeks (5 mg/kg and 20 mg/kg) after last injection. Ex vivo chromatographic analysis did not show significant changes in hippocampal glutamate concentrations; however, it showed similar results as obtained in the MRS study proving its validity. Taken together, the presented study provides new insight into glutamatergic involvement in rewarding properties of mephedrone.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available